Relief Therapeutics Holding AG (RLFTF)

[Whalatane]

Well they may be complimentary as opposed to direct competitors .
Lenzilumab is primarily designed to reduce damage to other organs thru reducing the cytokine storm associated with Covid.
RLF-100 is more directed to preserving / restoring the surfactant over the lung cells used for O2/CO2 exchange . So would not surprise me if patients get both... if both succeed in their trials.

Kiwi